Global Epidemiology of Plasmodium vivax

Global Epidemiology of Plasmodium vivax

Show other versions (1)

Plasmodium vivax is the most widespread human malaria, putting 2.5 billion people at risk of infection. Its unique biological and epidemiological characteristics pose challenges to control strategies which have been principally targeted against Plasmodium falciparum. Unlike P. falciparum, P. vivax i...

Bibliografske podrobnosti
Main Authors:	Howes, R, Battle, K, Mendis, K, Smith, D, Cibulskis, R, Baird, J, Hay, S
Format:	Journal article
Izdano:	American Society of Tropical Medicine and Hygiene 2016

Podobne knjige/članki

Global epidemiology of Plasmodium vivax
od: Howes, R, et al.
Izdano: (2016)

The global public health significance of Plasmodium vivax.
od: Battle, K, et al.
Izdano: (2012)

The epidemiology of Plasmodium vivax. Preface.
od: Hay, S, et al.
Izdano: (2013)

Geographical variation in Plasmodium vivax relapse
od: Battle, K, et al.
Izdano: (2014)

Geographical variation in Plasmodium vivax relapse.
od: Battle, K, et al.
Izdano: (2014)

Growing evidence of Plasmodium vivax across malaria-endemic Africa
od: Twohig, K, et al.
Izdano: (2019)

The global burden of Plasmodium vivax malaria is obscure and insidious
od: Battle, KE, et al.
Izdano: (2021)

Plasmodium vivax transmission in Africa
od: Howes, R, et al.
Izdano: (2015)

Defining the relationship between Plasmodium vivax parasite rate and clinical disease.
od: Battle, K, et al.
Izdano: (2015)

Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.
od: Baird, J, et al.
Izdano: (2018)

Epidemiology of Plasmodium vivax in Indonesia
od: Baird, J, et al.
Izdano: (2016)

Global economic costs due to Plasmodium Vivax malaria treatment and the cost-benefit of radical cure
od: Devine, A, et al.
Izdano: (2018)

Plasmodium vivax in the era of the shrinking P. falciparum map
od: Price, RN, et al.
Izdano: (2020)

The burden of Plasmodium vivax malaria
od: Battle, K
Izdano: (2015)

Plasmodium vivax Transmission in Africa.
od: Rosalind E Howes, et al.
Izdano: (2015-11-01)

The role of cytokines in Plasmodium vivax malaria
od: K. N. Mendis, et al.
Izdano: (1992-01-01)

A long neglected world malaria map: Plasmodium vivax endemicity in 2010.
od: Gething, P, et al.
Izdano: (2012)

Growing evidence of Plasmodium vivax across malaria-endemic Africa.
od: Katherine A Twohig, et al.
Izdano: (2019-01-01)

Attacking Plasmodium vivax
od: Baird, J
Izdano: (2016)

Diagnosis and treatment of Plasmodium vivax malaria.
od: Baird, K, et al.
Izdano: (2012)

Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms
od: J. Kevin Baird, et al.
Izdano: (2018-01-01)

Neglect of Plasmodium vivax malaria.
od: Baird, J
Izdano: (2007)

Chloroquine resistance in Plasmodium vivax.
od: Baird, J
Izdano: (2004)

The international limits and population at risk of Plasmodium vivax transmission in 2009
od: Guerra, C, et al.
Izdano: (2010)

THE HUMAN LIVER AS A RESERVOIR OF INFECTION: THE EPIDEMIOLOGY AND CONTROL OF MALARIA CAUSED BY PLASMODIUM VIVAX
od: Baird, J
Izdano: (2013)

Modelling the global constraints of temperature on transmission of Plasmodium falciparum and P. vivax.
od: Gething, P, et al.
Izdano: (2011)

Plasmodium falciparum and Plasmodium vivax epidemiology in an era of malaria elimination
od: E. Collins, et al.
Izdano: (2020-12-01)

Resistance to therapies for infection by Plasmodium vivax.
od: Baird, J
Izdano: (2009)

Pernicious and threatening Plasmodium vivax as reality.
od: Baird, J
Izdano: (2014)

Plasmodium vivax malaria endemicity in Indonesia in 2010
od: Elyazar, I, et al.
Izdano: (2012)

G6PD deficiency: global distribution, genetic variants and primaquine therapy.
od: Howes, R, et al.
Izdano: (2013)

G6PD Deficiency. Global Distribution, Genetic Variants and Primaquine Therapy
od: Howes, R, et al.
Izdano: (2013)

The effects of urbanization on global <it>Plasmodium vivax</it> malaria transmission
od: Qi Qiuyin, et al.
Izdano: (2012-12-01)

CAN THE SPATIAL DISTRIBUTION OF DUFFY NEGATIVITY EXPLAIN PLASMODIUM VIVAX ABSENCE IN AFRICA?
od: Howes, R, et al.
Izdano: (2009)

Diagnosis and treatment of Plasmodium vivax malaria
od: Baird, J, et al.
Izdano: (2016)

Spatial Epidemiology of Plasmodium vivax, Afghanistan
od: Simon Brooker, et al.
Izdano: (2006-10-01)

Epidemiology, drug resistance, and pathophysiology of Plasmodium vivax malaria
od: Kiran K Dayananda, et al.
Izdano: (2018-01-01)

Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission
od: Michael T White, et al.
Izdano: (2014-11-01)

Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000–17: a spatial and temporal modelling study
od: Battle, K, et al.
Izdano: (2019)

Management of Plasmodium vivax risk and illness in travelers
od: Baird, J
Izdano: (2017)